A remote Software Development role at Iambic Therapeutics, Inc. Engineer I: Minimum of 5 years of related experience with a Bachelor’s degree in a scientific field; or 3 years and a Master’s degree; PhD with 0-3 years of…
Keywords this role’s ATS scans for
Sydicom tailors your CV and cover letter to match these.
How Sydicom helps: we read this listing’s requirements and tune your CV and cover letter to the keywords its ATS (Ashby) is scanning for, wherever you are, then help you apply.
Original listing text, shown exactly as published by the company.
Engineer I
$129.6K – $162K
Engineer II
$152K – $190K
ABOUT IAMBIC THERAPEUTICS
Iambic is a clinical-stage life-science and technology company developing novel medicines using its AI-driven discovery and development platform. Based in San Diego and founded in 2020, Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters. The Iambic platform has demonstrated delivery of new drug candidates to human clinical trials with unprecedented speed and across multiple target classes and mechanisms of action. Iambic is advancing a pipeline of potential best-in-class and first-in-class clinical assets, both internally and in partnership, to address urgent unmet patient need. Learn more about the Iambic team, platform, pipeline, and partnerships at iambic.ai.
MISSION & CORE VALUES
Our mission is to deliver better medicines through innovations in AI-based discovery technologies. The culture and work at Iambic Therapeutics are profoundly strengthened by the diversity of our people and our differences in background, culture, national origin, religion, sexual orientation, and life experiences. We are committed to building an inclusive environment where a diverse group of talented humans work together to discover therapeutics and create technologies.
Iambic Therapeutics, Inc
Software Development
8 open roles on Sydicom
Iambic Therapeutics, Inc. is a biotechnology company focused on discovering and developing novel small molecule therapeutics, primarily for oncology. The company leverages an AI-driven drug discovery platform to accelerate the development of precision medicines.
Generated by Sydicom AI